METLIFE INC (MET) Stock Analyst Earnings Estimates
NYSE:MET - New York Stock Exchange, Inc. - US59156R1086 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 69.898B -1.66% | 66.851B -4.36% | 71.048B 6.28% | 76.128B 7.15% | 78.94B 3.69% | 82.25B 4.19% | 86.961B 5.73% | |
| EBITDA YoY % growth | 4.47B -54.11% | 3.871B -13.40% | 7.435B 92.07% | 8.02B 7.87% | 8.683B 8.27% | N/A | N/A | |
| EBIT YoY % growth | 3.797B -58.03% | 3.153B -16.96% | 6.721B 113.16% | 8.413B 25.17% | 8.833B 4.99% | 10.066B 13.96% | 8.746B -13.11% | |
| Operating Margin | 5.43% | 4.72% | 9.46% | 11.05% | 11.19% | 12.24% | 10.06% | |
| EPS YoY % growth | 6.84 -25.08% | 7.34 7.31% | 8.14 10.90% | 9.04 11.07% | 10.36 14.63% | 11.47 10.65% | 12.83 11.85% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.17 -4.87% | 2.39 22.48% | 2.44 17.12% | 2.28 16.23% | 2.66 22.52% | 2.72 13.75% | 2.73 11.93% | 2.57 12.74% | 2.94 10.62% | 2.98 9.75% | 2.95 8.19% |
| Revenue Q2Q % growth | 18.72B 0.20% | 18.865B 7.10% | 19.342B -2.01% | 19.076B 1.32% | 19.866B 6.12% | 20.085B 6.47% | 20.327B 5.09% | 19.861B 4.12% | 21.737B 9.42% | 21.91B 9.09% | 22.422B 10.31% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.745B 18.39% | 1.919B -16.93% | 1.897B 14.28% | 1.541B -3.57% | 1.725B -1.15% | 1.762B -8.18% | 1.738B -8.38% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.96 7.10% | 2.02 | -0.06 | -2.86% |
| Q4 2024 Q2Q % growth | 2.08 7.77% | 2.12 | -0.04 | -1.74% |
| Q3 2024 Q2Q % growth | 1.95 | 2.19 | -0.24 | -10.99% |
| Q2 2024 Q2Q % growth | 2.28 17.53% | 2.12 | 0.16 | 7.34% |
| Q1 2024 Q2Q % growth | 1.83 20.39% | 1.83 | 0.00 | -0.11% |
| Q4 2023 Q2Q % growth | 1.93 24.52% | 1.91 | 0.02 | 1.12% |
| Q3 2023 Q2Q % growth | 1.95 61.16% | 1.96 | -0.01 | -0.36% |
| Q2 2023 Q2Q % growth | 1.94 -3.00% | 1.89 | 0.05 | 2.82% |
| Q1 2023 Q2Q % growth | 1.52 -26.92% | 1.85 | -0.33 | -17.73% |
| Q4 2022 Q2Q % growth | 1.55 -28.57% | 1.66 | -0.11 | -6.87% |
| Q3 2022 Q2Q % growth | 1.21 -49.37% | 1.19 | 0.02 | 2.07% |
| Q2 2022 Q2Q % growth | 2.00 -15.61% | 1.46 | 0.54 | 36.53% |
| Q1 2022 Q2Q % growth | 2.08 -5.45% | 1.67 | 0.41 | 24.84% |
| Q4 2021 Q2Q % growth | 2.17 6.90% | 1.49 | 0.68 | 46.11% |
| Q3 2021 Q2Q % growth | 2.39 38.15% | 1.75 | 0.64 | 36.22% |
| Q2 2021 Q2Q % growth | 2.37 185.54% | 1.64 | 0.73 | 44.60% |
| Q1 2021 Q2Q % growth | 2.20 39.24% | 1.55 | 0.65 | 42.25% |
| Q4 2020 Q2Q % growth | 2.03 2.53% | 1.53 | 0.50 | 32.28% |
| Q3 2020 Q2Q % growth | 1.73 36.22% | 1.63 | 0.10 | 6.20% |
| Q2 2020 Q2Q % growth | 0.83 -39.86% | 0.91 | -0.08 | -8.93% |
| Q1 2020 Q2Q % growth | 1.58 6.76% | 1.45 | 0.13 | 8.81% |
| Q4 2019 Q2Q % growth | 1.98 | 1.39 | 0.59 | 42.56% |
| Q3 2019 Q2Q % growth | 1.27 | 1.41 | -0.14 | -9.87% |
| Q2 2019 Q2Q % growth | 1.38 | 1.35 | 0.03 | 2.14% |
| Q1 2019 Q2Q % growth | 1.48 | 1.29 | 0.19 | 14.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 18.827B 10.64% | 18.345B | 482M | 2.63% |
| Q4 2024 Q2Q % growth | 19.738B 5.45% | 19.699B | 39M | 0.20% |
| Q3 2024 Q2Q % growth | 17.614B -3.42% | 18.844B | -1.23B | -6.53% |
| Q2 2024 Q2Q % growth | 18.683B 0.26% | 18.754B | -71M | -0.38% |
| Q1 2024 Q2Q % growth | 17.016B 5.52% | 17.905B | -889M | -4.97% |
| Q4 2023 Q2Q % growth | 18.718B 14.72% | 18.641B | 77M | 0.41% |
| Q3 2023 Q2Q % growth | 18.237B -18.16% | 17.856B | 381M | 2.13% |
| Q2 2023 Q2Q % growth | 18.634B 20.42% | 17.082B | 1.552B | 9.09% |
| Q1 2023 Q2Q % growth | 16.126B 4.68% | 17.041B | -915M | -5.37% |
| Q4 2022 Q2Q % growth | 16.316B -18.78% | 17.491B | -1.175B | -6.72% |
| Q3 2022 Q2Q % growth | 22.283B 31.81% | 20.787B | 1.496B | 7.20% |
| Q2 2022 Q2Q % growth | 15.474B -16.47% | 16.268B | -794M | -4.88% |
| Q1 2022 Q2Q % growth | 15.405B -1.01% | 16.945B | -1.54B | -9.09% |
| Q4 2021 Q2Q % growth | 20.089B 3.46% | 17.846B | 2.243B | 12.57% |
| Q3 2021 Q2Q % growth | 16.905B 5.56% | 16.444B | 461M | 2.80% |
| Q2 2021 Q2Q % growth | 18.524B 31.39% | 16.044B | 2.48B | 15.46% |
| Q1 2021 Q2Q % growth | 15.562B -15.01% | 16.127B | -565M | -3.50% |
| Q4 2020 Q2Q % growth | 19.418B 12.42% | 16.502B | 2.916B | 17.67% |
| Q3 2020 Q2Q % growth | 16.015B -14.26% | 16.161B | -146M | -0.90% |
| Q2 2020 Q2Q % growth | 14.099B -19.42% | 15.229B | -1.13B | -7.42% |
| Q1 2020 Q2Q % growth | 18.31B 12.32% | 16.448B | 1.862B | 11.32% |
| Q4 2019 Q2Q % growth | 17.273B | 16.987B | 286M | 1.68% |
| Q3 2019 Q2Q % growth | 18.678B | 16.552B | 2.126B | 12.84% |
| Q2 2019 Q2Q % growth | 17.497B | 16.715B | 782M | 4.68% |
| Q1 2019 Q2Q % growth | 16.302B | 16.115B | 187M | 1.16% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -6.34% | -7.2% | -1.92% | -2.6% |
| Revenue | -0.19% | -1.49% | 0.32% | -0.11% |